PMID- 35472247
OWN - NLM
STAT- MEDLINE
DCOM- 20221108
LR  - 20221207
IS  - 2042-7174 (Electronic)
IS  - 0961-7671 (Linking)
VI  - 30
IP  - 5
DP  - 2022 Nov 4
TI  - A randomized controlled trial of a pharmacist-led intervention to enhance 
      knowledge of Vietnamese patients with type 2 diabetes mellitus.
PG  - 449-456
LID - 10.1093/ijpp/riac030 [doi]
AB  - OBJECTIVES: We aimed to assess whether a pharmacist-led intervention enhances 
      knowledge, medication adherence and glycemic control in patients with type 2 
      diabetes mellitus (T2DM). METHODS: We conducted a single-blinded randomized 
      controlled trial in Vietnam. Individuals with T2DM were recruited from a general 
      hospital and randomly allocated to intervention and routine care. The 
      intervention group received routine care plus counselling intervention by a 
      pharmacist, including providing drug information and answering individual 
      patients' queries relating to T2DM and medications, which had not been done in 
      routine care. We assessed the outcomes: knowledge score as measured by the 
      Diabetes Knowledge Questionnaire, self-reported adherence and fasting blood 
      glucose (FBG) at the 1-month follow-up. KEY FINDINGS: A total of 165 patients (83 
      intervention, 82 control) completed the study; their mean age was 63.33 years, 
      and 49.1% were males. The baseline characteristics of the patients were similar 
      between the groups. At 1-month follow-up, the pharmacist's intervention resulted 
      in an improvement in all three outcomes: knowledge score [B = 5.527; 95% 
      confidence intervals (CI): 3.982 to 7.072; P < 0.001], adherence [odds ratio (OR) 
      = 9.813; 95% CI: 2.456 to 39.205; P = 0.001] and attainment of target FBG (OR = 
      1.979; 95% CI: 1.029 to 3.806; P = 0.041). CONCLUSIONS: The pharmacist-led 
      intervention enhanced disease knowledge, medication adherence and glycemic 
      control in patients with T2DM. This study provides evidence of the benefits of 
      pharmacist counselling in addition to routine care for T2DM outpatients in a 
      Vietnam population.
CI  - (c) The Author(s) 2022. Published by Oxford University Press on behalf of the Royal 
      Pharmaceutical Society. All rights reserved. For permissions, please e-mail: 
      journals.permissions@oup.com.
FAU - Nguyen, Thao H
AU  - Nguyen TH
AD  - Department of Clinical Pharmacy, University of Medicine and Pharmacy at Ho Chi 
      Minh City, Ho Chi Minh City, Vietnam.
FAU - Tran, Tam T T
AU  - Tran TTT
AD  - Faculty of Pharmacy, Hau Giang General Hospital, Hau Giang Province, Vietnam.
FAU - Nguyen, Nguyet K
AU  - Nguyen NK
AD  - Department of Pharmacology and Clinical Pharmacy, Can Tho University of Medicine 
      and Pharmacy, Can Tho, Vietnam.
FAU - Diep, Han G
AU  - Diep HG
AD  - Department of Pharmacology and Clinical Pharmacy, Can Tho University of Medicine 
      and Pharmacy, Can Tho, Vietnam.
FAU - Vo, Son D
AU  - Vo SD
AD  - Faculty of Pharmacy, Hau Giang General Hospital, Hau Giang Province, Vietnam.
FAU - Taxis, Katja
AU  - Taxis K
AD  - Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The 
      Netherlands.
FAU - Pham, Suol T
AU  - Pham ST
AD  - Department of Pharmacology and Clinical Pharmacy, Can Tho University of Medicine 
      and Pharmacy, Can Tho, Vietnam.
FAU - Nguyen, Thang
AU  - Nguyen T
AUID- ORCID: 0000-0001-7799-4523
AD  - Department of Pharmacology and Clinical Pharmacy, Can Tho University of Medicine 
      and Pharmacy, Can Tho, Vietnam.
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
PL  - England
TA  - Int J Pharm Pract
JT  - The International journal of pharmacy practice
JID - 9204243
SB  - IM
MH  - Male
MH  - Humans
MH  - Middle Aged
MH  - Female
MH  - *Diabetes Mellitus, Type 2/drug therapy
MH  - Pharmacists
MH  - Vietnam
MH  - Medication Adherence
MH  - Asian People
OTO - NOTNLM
OT  - Vietnam
OT  - knowledge
OT  - pharmacist-led intervention
OT  - type 2 diabetes mellitus
EDAT- 2022/04/27 06:00
MHDA- 2022/11/09 06:00
CRDT- 2022/04/26 17:20
PHST- 2021/08/26 00:00 [received]
PHST- 2022/03/22 00:00 [accepted]
PHST- 2022/04/27 06:00 [pubmed]
PHST- 2022/11/09 06:00 [medline]
PHST- 2022/04/26 17:20 [entrez]
AID - 6574472 [pii]
AID - 10.1093/ijpp/riac030 [doi]
PST - ppublish
SO  - Int J Pharm Pract. 2022 Nov 4;30(5):449-456. doi: 10.1093/ijpp/riac030.